New Mom's Lesson About Giving Birth in US Stuns: 'Too European for This'
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
A mother of newborn twins has sparked a viral conversation after sharing her theory on why fertility rates in the United States are reaching historic lows.
Emily Fish, 36, from Ohio, posted a TikTok video (@_e_fish_) on July 17 reflecting on her recent birth experience and the bills that followed. Her clip, which has racked up over 831,000 views, offers a personal lens on the broader national trend of declining childbirth.
The Centers for Disease Control and Prevention (CDC) says that the general fertility rate in the U.S. declined by 3 percent in 2023, hitting an all-time low.
Fish says that the reason people are having fewer children might not lie in personal lifestyle choices, but in something more tangible.
"Maybe it's because the cost of having a baby in America is over six figures, and that's just to get through the hospital and back home," Fish said in the video.
Fish can be speaking to the camera while holding one of her babies.
Fish can be speaking to the camera while holding one of her babies.
TikTok/@_e_fish_
'They've Already Been Billed More Than My Student Loans'
The financial platform Credit Karma says that raising a child is now more expensive than ever. A 2017 study by the U.S. Department of Agriculture estimated the cost of raising one child to age 17 at $233,610 for a middle-income family. Adjusted for inflation, that figure jumps to $318,949 for a baby born in February 2025.
Fish gave birth to twin daughters five weeks ago via a scheduled C-section at 37 weeks, after a pregnancy that required intensive monitoring due to fetal growth concerns. Starting at 22 weeks, she had twice-weekly appointments, leading up to her delivery and four-day hospital stay.
Fish's insurance was billed a total of $120,527.51, though she personally paid $2,788.70 out of pocket. "I am very fortunate; I have great insurance, and I have a low deductible," she said.
Each of Fish's newborns was also billed separately—Baby A at $15,124.55, and Baby B at $14,872.55.
"So I guess there was some sort of sibling discount," Fish said. "They're not even able to blink yet, and they've already been billed more than the total cost of my student loans," she added.
One of the most-surprising charges came when she experienced a headache at seven months pregnant. Although Fish's blood pressure was only slightly elevated, she said the hospital tested for preeclampsia, monitored the babies' heart rates, gave her two extra-strength Tylenol pills, and performed blood work. The bill? $9,115.
Delivery and postpartum care alone came to $65,665.50.
"I'm very grateful for the experience that I had and great insurance, but I know, for a lot of people that live in America, that is simply not possible," Fish said. "I probably would have had to file bankruptcy," she added.
Americans Rethink Parenthood
Indeed, money is on many Americans' minds when considering starting a family. A Pew Research Center survey of 770 adults aged 18 to 49 found that not having children made it easier to afford the things they want, pursue hobbies, save for the future, and even advance in their careers or maintain a social life.
The survey also found that the most-common reason for not having children was simply not wanting them. Sixty-four percent of women under 50 cited that reason, compared to 50 percent of men.
TikTok Reacts
So far, the video has garnered over 180,000 likes and more than 6,100 comments—many from shocked viewers outside the United States who expressed disbelief at the high costs.
"In the UK you pay for parking and that's it," said one user.
"That's wild. So having children is only for the rich in the U. S.?" asked another.
"The world is so over populated too like. it's O.K. if some people don't want kids," said a third commenter. Fish replied, "I agree—people can choose without judgment. But raising a family should be financially accessible for those who want that life."
One comment read: "I'm too European for this."
Newsweek is waiting for @_e_fish_ to provide a comment.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Business News
an hour ago
- Time Business News
How to Use Influencer-Generated Content in Your Social Media Ads
If you're working with influencers, you already have impactful content for your social media ads. In fact, brands sharing creator-based ads see a 15% boost in return on ad spend compared to traditional campaigns. Influencer-generated content (IGC) outperforms standard brand ads because it feels real and on-brand. But to turn those posts into high-performing ads, you'll need usage rights, clean formatting, and a plan for testing. It also helps to know which pieces of influencer content are worth promoting and how to adjust them for platforms like Meta, TikTok, or YouTube. In this article, we'll explain how to get the most out of influencer content and optimize your advertising budget. Even the best strategy won't land if the influencer isn't the right fit. So before you talk about budget or brainstorm content ideas, look closely at who you're teaming up with. If you're not sure where to begin, a full-stack influencer marketing agency can help you find creators who already speak to your target audience and match your brand's tone. You want someone who already speaks to the people you're trying to reach. If their followers match your target audience, their content will feel more relevant and relatable. Scroll their feed. Does it feel like something your brand would post? If the tone, visuals, or vibe feel way off, it'll be harder to make it work for your ads. Most high-performing social ads are short-form, like TikTok or Instagram Reels. Look for creators who know how to grab attention through reels. Choose someone who keeps people engaged with short-form content. Always think long-term. Reusing influencer content in multiple ads or platforms can save time and boost consistency. Plus, seeing a familiar face more than once builds trust with your audience. If you're planning to turn influencer content into social media ads, get it in writing. That agreement should lay out how you're allowed to use the content, so everyone's on the same page from the start. Discuss how long the ad copy will run. Being specific helps avoid confusion and clarifies expectations for both parties. Make sure it's clear where the content will show up. The influencer should know which platforms their work will appear on. Each platform has its vibe and requirements, so this helps everyone plan accordingly. Be transparent about what edits you're allowed to make and who made them. This keeps the content true to its creator while still working for your brand. To get better results from your ads, match the content to where someone is in their decision-making process. Then use the type of content that meets their needs. At this stage, people might not know your brand yet. Your goal is to stop the scroll and spark curiosity. Use fun, relatable videos and influencer content that feels natural on their feed. By now, they know your name, but they're not sold yet. Give them a closer look at what you offer. Use product demos, day-in-the-life clips, or reviews to show how your product fits into their world. They're almost ready to buy at this point. Use influencer content such as testimonials, before-and-after photos, or answers to common questions. The goal is to clear up doubts and help them feel confident hitting the 'buy' button. Experiment with different creators, hooks, captions, visuals, and calls to action to see what works for your campaign. Monitoring influencer content closely can help you get closer to your goals. This shows how long someone pauses while scrolling. The longer they stay, the more effective your content is at grabbing attention. This shows how much of the video your audience is watching. If they drop off early, your intro might not be pulling them in. If they stick around, that's a sign your message is landing. Likes, comments, shares, and saves show how people feel about your social media ads. Strong engagement typically means your influencer content feels natural and relevant to the audience. Whether you're tracking product sales, sign-ups, or site visits, these metrics tell you which influencer content is turning into purchase decisions. To get better performance, your influencer content should feel like it belongs on the platform where it's posted. Here's what to keep in mind when formatting your ad for TikTok, Meta, YouTube, or wherever it's running. Vertical videos (9:16) work best for TikTok and Instagram Reels. If you upload a square or horizontal video where it doesn't belong, it may look awkward and out of place. Captions also make your content easier to follow, whether you're explaining something or sharing an important message, like an upcoming discount or sale. A voiceover can make your message more personal and engaging. And on platforms like TikTok, using trending sounds or music can give your social media ads an extra boost. Don't overlook stickers, polls, filters, and hashtags. These extras help your influencer-generated content blend naturally into the feed. When an ad feels native, it gets more attention and engagement. Influencer-generated content can help you build real trust with your audience. So next time you're putting together a campaign, don't just lean on your in-house marketing team. A full-stack influencer marketing agency can help transform creator content into scroll-stopping ads. They know how to find the right creators, nurture long-term partnerships, and turn everyday posts into ads that convert. TIME BUSINESS NEWS
Newsweek
an hour ago
- Newsweek
List of Places Where Tesla Faces Legal Action Over Self-Driving Cars
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Tesla, headed by CEO Elon Musk, has come under increasing legal scrutiny worldwide over its self-driving technology, with lawsuits and regulatory actions unfolding in France, Australia, Florida, and California. Many of the cases share a common theme of criticizing Tesla's advertising, with lawyers saying that the company's claims of "autonomous vehicles" fail to live up to reality. Newsweek contacted Tesla for more information on the legal action via email. The Context Tesla's global sales have struggled in 2025, with developing foreign competition further threatening its leading position in key markets, and backlash against CEO Elon Musk's role in President Donald Trump's administration resulting in protests and boycotts of the company's vehicles. The legal challenges across the world mean Tesla has further issues to deal with, despite Musk's departure from the White House. France In France, the government has ordered Tesla to fix a series of violations over deceptive business practices, with the company facing daily fines of $58,000 if it fails to comply. French regulators determined that Tesla's "autonomous driving" features do not meet the standard implied by the company's marketing, and said that the company misled buyers by overstating the power of its autonomous driving technology. A Tesla electric car retail store and company brand logo sign at night, Wuhan, China, May 2nd 2024. A Tesla electric car retail store and company brand logo sign at night, Wuhan, China, May 2nd 2024. Getty Images Australia Thousands of Australian Tesla owners have joined a class action alleging "phantom braking" and misleading claims about the vehicles' capabilities and performance. Plaintiffs describe repeated, sudden, and unexplained braking events while using Tesla's Autopilot system, with some incidents leading to collisions or dangerous situations. "Drivers have reported feeling completely terrified when their vehicles have braked suddenly and it has led in some cases to collisions," said class action lawyer Rebecca Jancauskas in an interview in June. "We've had many reports of people who registered for this class action, telling us that they've been driving with their hands on the vehicle, fully alert, and these issues have occurred nonetheless." Florida In Miami, Florida, a federal jury trial is underway following a fatal 2019 crash involving a Tesla Model S using its Autopilot system. Plaintiffs claim Tesla exaggerated the abilities of its self-driving features, encouraging drivers—like George McGee, who admitted distraction at the wheel—to become over-reliant on the technology. The crash led to the death of Naibel Benavides Leon and severe injury to her companion. George McGee said in court, "I trusted the technology too much," acknowledging he took his attention off the road because of his confidence in the autopilot. The trial, overseen by U.S. District Judge Beth Bloom, is expected to set a precedent for how driver-assistance technologies are marketed and what obligations manufacturers bear. California The California Department of Motor Vehicles has filed a lawsuit seeking to halt Tesla sales and manufacturing in the state for at least 30 days. The Department accuses Tesla of making false and misleading claims about its autopilot and full self-driving capabilities, alleging the features are advertised as being more autonomous than they actually are. Attorney General Rob Bonta said in a statement, "These labels and descriptions represent specifically that respondent [Tesla]'s vehicles will operate as autonomous vehicles, which they could not and cannot do". What Happens Next The outcomes of these legal actions may have wide-reaching implications for Tesla and the broader self-driving automotive sector. In California, the DMV's lawsuit could result in a month-long suspension of Tesla's sales and manufacturing, potentially influencing how all automakers market advanced driver assistance systems.
Newsweek
an hour ago
- Newsweek
Health Care Data CEO Gets Real About Wearables
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. This is a preview of Access Health—Tap here to get this newsletter delivered straight to your inbox. Good morning. Moody's released its quarterly health care report on Tuesday. Let's take a look at the highlights. Moody's quarterly paints a sobering picture for hospitals and health systems. The biggest headline, unsurprisingly, is that Medicaid cuts are coming—and they're steep. The newly enacted federal budget reconciliation law is projected to slash Medicaid spending by $1.1 trillion through 2034, compared to previous projections from the Congressional Budget Office. This could leave hospitals with more uninsured patients and fewer reimbursement dollars, especially safety-net and rural providers. Congress' next moves will determine the exact conditions of this new normal. If lawmakers do not extend expanded premium tax credits for the Affordable Care Act by the end of the year, the CBO estimates that the number of uninsured Americans would increase by at least 4.2 million. Republicans are not keen on this measure, but it's still possible that they could compromise with Democrats to get other key GOP health care policies passed. One of those key policies is pharmacy benefit manager (PBM) reform, something that, historically, has garnered bipartisan support. They've been criticized by lawmakers on both sides of the aisle for overcharging for medications. Cigna, CVS Health and UnitedHealth—which together own 80 percent of the PBM market—face a credit risk if the government does crack down, according to Moody's. For more on the Congressional health care standoff, read on to the next section. Insurers' finances are also in a precarious position. On the bright side, CMS' Medicare Advantage reimbursement rate is rising to 5.1 percent in 2026. This is likely to float the industry to more typical earnings and margins after a period of weak performance, Moody's projects. But its analysts aren't sure how long it will take to regulate. For now, they gave health insurers a "negative" outlook due to higher-than-expected spending, particularly on weight-loss drugs and behavioral health care. I'll end on a positive note. Moody's analyzed CMS data, which suggests that the independent dispute resolution (IDR) process is becoming more efficient. The No Surprises Act (NSA) has been a headache for many providers since it was enacted in 2022, but the process is finally hitting its stride, per the numbers. New IDR claims continued to increase throughout 2024, but the number of resolved claims began to surpass new claims starting in the third quarter. "This, along with a consistently high provider win rate in disputes, suggests a decline in NSA-related accounts receivable and an easing of liquidity stress," Moody's analysts said in the report. How are you feeling about your organization's financial situation as we head into the latter half of 2025? Let me know at In Other News Major health care headlines from the week Congressional Republicans are hoping to pass a bipartisan health care package by year's end, with proposals to rein in pharmacy benefit managers (PBMs), expand Medicare coverage for weight-loss drugs and boost cancer screenings. But Democrats—frustrated by deep Medicaid cuts in the recent GOP megabill—are demanding Affordable Care Act tax credit extensions as a condition for talks, according to Politico. But Democrats—frustrated by deep Medicaid cuts in the recent GOP megabill—are demanding Affordable Care Act tax credit extensions as a condition for talks, according to Politico. The standoff highlights deep partisan tensions over health care, with both sides weighing how much they're willing to trade to secure their policy wins. Bankrupt hospital operator Steward Health Care has filed a lawsuit against its former CEO Ralph de la Torre and three other executives, alleging they harmed the company "through their greed and bad faith misconduct." and three other executives, alleging they harmed the company "through their greed and bad faith misconduct." A spokesperson for de la Torre told the Telegram & Gazette that he denies the allegations. Massachusetts-based Steward filed for bankruptcy in May 2024, subsequently closing two hospitals and selling others. De la Torre has previously been criticized for buying a megayacht while the system was in financial and legal turmoil. Hims & Hers is facing a lawsuit from a group of its shareholders , alleging the telehealth platform's senior executives and board gave misleading statements to investors. , alleging the telehealth platform's senior executives and board gave misleading statements to investors. The plaintiffs claim that Hims & Hers misrepresented its short-lived partnership with Novo Nordisk , which was announced in April and terminated by the pharmaceutical company in late June. Hims & Hers allegedly told investors that it could offer both Novo Nordisk's Wegovy and compounded semaglitude under the agreement—which Novo Nordisk has denied, calling the sale "deceptive" and claiming it "put patient safety at risk." , which was announced in April and terminated by the pharmaceutical company in late June. Hims & Hers allegedly told investors that it could offer both Novo Nordisk's Wegovy and compounded semaglitude under the agreement—which Novo Nordisk has denied, calling the sale "deceptive" and claiming it "put patient safety at risk." The investors' lawsuit also claims that Hims & Hers falsely represented the legality of compounded semaglutide sales, and told them it was compliant with FDA regulations. The Alice L. Walton School of Medicine has officially opened in Bentonville, Arkansas, TIME reported. Walton—Walmart heiress and the world's richest woman—will cover tuition for the first five graduating classes. Pulse Check Executive perspectives on key industry issues Jannine Versi is the CEO and co-founder of Elektra Health. Jannine Versi is the CEO and co-founder of Elektra Health. Elektra Health We're gearing up for our Women's Global Impact event on August 5 in New York City, and a number of health care leaders will be in attendance from companies like MUSC, the American Heart Association, Northwell Health and Virtua Health. During our health care spotlight panel, we'll discuss the leadership gender gap in the industry and explore how women executives are working to bring more attention to female health issues. For this week's Pulse Check, I'm bringing you a sneak peek from my interview with Jannine Versi, co-founder and CEO of Elektra Health. The company aims to "smash the menopause taboo" via its telehealth clinic, educational materials and private community for women. Here's what Versi told me about her journey and priorities: Has being a woman shaped your leadership style or the way that you think about your work in the health care industry? Absolutely. I know what it feels to be dismissed or minimized or told by a provider "that's just PMS" "or you need to manage your stress" in an offhanded way when something feels wrong. In terms of my team, we are female-founded and predominantly identify as women, but I actually don't think that changes how I try to lead — with urgency and empathy and also, with a high bar because our patients deserve the best. Women make up 70 percent of the global health care workforce, but hold just 25 percent of the industry's leadership positions. What do you make of this gender gap? How might we begin to close it? This gap is a moral issue and a missed opportunity. Women are the engine of the health care system, yet their perspectives are often missing from the rooms where decisions get made. That disconnect affects everything from research agendas to benefit design. We need more women at the helm of health systems, on investment committees and leading companies. But we also need systems that are built to retain and promote them. That means flexible leadership paths, accountability on gender metrics and real investment in women-led innovation. Put differently, I believe in the power of diversity, equity and inclusion. I also want to call out a couple partner organizations – like the University of Pittsburgh Medical Center (UPMC) and Emblem Health — both led by women — which aren't just talking about women's health. They're investing in it meaningfully because it's smart and strategic for their business and the right thing to do in serving patients and members. Meanwhile, I have heard for a long time from various payers and systems that they are "still figuring out" their women's health strategy. I suspect some will regret not moving more swiftly because women are increasingly and rightly expecting better from their providers and insurers. That kind of leadership sets a new standard—and hopefully, it's just the beginning. Register here to see Versi speak live at Newsweek's Women's Global Impact Summit in New York City on August 5. C-Suite Shuffles Where health care leaders are coming and going Bill Gassen has been chair-elect of the American Hospital Association. The Sanford Health CEO will assume the seat in 2027, making him the AHA's top elected official. has been named The Sanford Health CEO will assume the seat in 2027, making him the AHA's top elected official. Click here to snag a ticket! Gassen will be speaking at Newsweek's Digital Health Care Forum on September 16 in New York City. I'll be moderating the conversation, discussing the business case for technology and innovation. Howard University Hospital Corporation in Washington, D.C., has selected Kerry Watson as its interim CEO, effective August 1. This won't be his first time at the safety-net health system; he worked there as an administrator from 1982 to 1992. Watson has held numerous executive roles at health systems across the U.S., including service as interim CEO of UF Health St. Johns, CEO of Maui Health System and president of Wellstar Atlanta Medical Center (which shuttered in 2022). UC Davis Health has has announced three changes to its leadership team, selecting an interim CEO, interim vice chancellor of human health sciences and permanent dean of the School of Medicine. Dr. David Lubarsky, former CEO and vice chancellor of human health sciences, retired in February to become president and CEO of Westchester Medical Center Health Network in his home state of New York. to become president and CEO of Westchester Medical Center Health Network in his home state of New York. The California health system has divided his former positions amongst Michael Condrin (interim CEO) and Dr. Bruce Lee Hall (interim vice chancellor of human health sciences). Condrin most recently served as UC Davis Medical Center's chief operating officer, while Hall was the enterprise's chief clinical officer. (interim CEO) and (interim vice chancellor of human health sciences). Condrin most recently served as UC Davis Medical Center's chief operating officer, while Hall was the enterprise's chief clinical officer. Dr. Susan Murin assumed the top role at the School of Medicine in January, reporting to Hall. She has been with UC Davis Health for 29 years, previously as vice dean for clinical affairs and executive director of its medical group. Executive Edge How health care execs are managing their own health Dr. Mitesh Rao is the founder and CEO of OMNY Health. Dr. Mitesh Rao is the founder and CEO of OMNY Health. OMNY Health For this week's Executive Edge, I connected with Dr. Mitesh Rao, founder and CEO of the health care data platform OMNY Health. I've featured him before for his insights on wearable technology and how he uses it to monitor his health while balancing a busy work and travel schedule. In late June, at a House Energy Committee hearing, HHS Secretary Robert F. Kennedy Jr., told lawmakers that wearables will be "key" to his "Make America Healthy Again" (or "MAHA") agenda. He hopes that every American will be wearing one of these devices in the next four years—a goal that sparked significant debate about wearables' data security and efficacy. I followed up with Rao to get his latest take on wearable tech in health care. Here's what he told me: "Wearables have become a hot topic in health care, especially after RFK Jr. touted plans to get every American wearing one, then quickly backed off. I wear an Oura ring daily and have tried a variety of different wearables, including a Fitbit and a Google Watch, which I found more distracting than helpful." "What keeps me coming back to wearables isn't the reminders to stand up or go for a walk--it's the data. I enjoy seeing how my sleep quality changes after a long week of work travel, or how my body responds to things like a late dinner or a skipped workout. These are helpful personal reminders and insights, but it doesn't necessarily mean I will eat dinner earlier tomorrow or skip my next work trip." These are helpful personal reminders and insights, but it doesn't necessarily mean I will eat dinner earlier tomorrow or skip my next work trip." "That said, I do see value in wearable data in the clinical setting, and research shows 94 percent of people who use one are open to sharing their data with their doctor . However, as someone who has devoted their career to democratizing access to health care data, I believe we need to address some major privacy concerns before rushing to use these insights for research." . However, as someone who has devoted their career to democratizing access to health care data, I believe we need to address some major privacy concerns before rushing to use these insights for research." " Think about 23andMe . A few years ago, everyone was quick to take the saliva test, but when they filed for bankruptcy, people immediately realized 'Wait, my DNA could be sold in a fire sale?'" . A few years ago, everyone was quick to take the saliva test, but when they filed for bankruptcy, people immediately realized 'Wait, my DNA could be sold in a fire sale?'" "If wearable data is going to be used responsibly, we must always make sure it benefits people more than it benefits platforms. This begins with transparency. Every time I've set up a new wearable device for myself, I've chosen not to allow it to share my data for 'research' because I've no insight into how or what is being done with that data, or how it will be secured and protected. Until this is made clear for users, we're not ready to apply it meaningfully in health care." Before you go, check out Dr. Lawrence Rosenberg's reflection on what "excellence" actually means in health care. He is the president and CEO of the Integrated Health & Social Services University Network for West-Central Montreal, and a member of Newsweek's CEO Circle. This is a preview of Access Health—Tap here to get this newsletter delivered straight to your inbox.
